BioWorld Asia

Dec. 24, 2003

NeuroSearch Guaranteed EUR82M In GlaxoSmithKline CNS Pact

Danish drug development firm NeuroSearch A/S and GlaxoSmithKline plc entered an alliance focused on the major diseases of the central nervous system. (BioWorld International Read More

Gyros Raises SEK145M To Grow CD-Based Microfluidics Platform

Red Cell Protein Holds Clue To New Malaria Vaccines, Therapies

Picking Up Steam, New Vernalis Signs Cancer Deal With Novartis

Novagali Launches Phase I Trial, Negotiates Second-Round Funds

European Union Agrees On New Framework For Pharmaceuticals

UroGene, SGX To Develop Kinase Inhibitors For Urological Cancers

EU Generally Accepting Of New Rules For Tissues, Cells

Galapagos, Bayer Agree On Deal Using SilenceSelect Technology

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 26, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 27, 2026.

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

Muted and missing M&As: JPM deals absent in 2026

BioWorld

For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...

Brain-derived tau in blood predicts stroke severity and outcome

BioWorld Science

Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...